Details
Stereochemistry | ACHIRAL |
Molecular Formula | C21H23ClFNO2 |
Molecular Weight | 375.864 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
OC1(CCN(CCCC(=O)C2=CC=C(F)C=C2)CC1)C3=CC=C(Cl)C=C3
InChI
InChIKey=LNEPOXFFQSENCJ-UHFFFAOYSA-N
InChI=1S/C21H23ClFNO2/c22-18-7-5-17(6-8-18)21(26)11-14-24(15-12-21)13-1-2-20(25)16-3-9-19(23)10-4-16/h3-10,26H,1-2,11-15H2
Molecular Formula | C21H23ClFNO2 |
Molecular Weight | 375.864 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:28:50 UTC 2023
by
admin
on
Fri Dec 15 16:28:50 UTC 2023
|
Record UNII |
J6292F8L3D
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
LIVERTOX |
NBK548393
Created by
admin on Fri Dec 15 16:28:50 UTC 2023 , Edited by admin on Fri Dec 15 16:28:50 UTC 2023
|
||
|
NDF-RT |
N0000180182
Created by
admin on Fri Dec 15 16:28:50 UTC 2023 , Edited by admin on Fri Dec 15 16:28:50 UTC 2023
|
||
|
WHO-ATC |
N05AD01
Created by
admin on Fri Dec 15 16:28:50 UTC 2023 , Edited by admin on Fri Dec 15 16:28:50 UTC 2023
|
||
|
WHO-ESSENTIAL MEDICINES LIST |
24.1
Created by
admin on Fri Dec 15 16:28:50 UTC 2023 , Edited by admin on Fri Dec 15 16:28:50 UTC 2023
|
||
|
WHO-VATC |
QN05AD01
Created by
admin on Fri Dec 15 16:28:50 UTC 2023 , Edited by admin on Fri Dec 15 16:28:50 UTC 2023
|
||
|
NCI_THESAURUS |
C323
Created by
admin on Fri Dec 15 16:28:50 UTC 2023 , Edited by admin on Fri Dec 15 16:28:50 UTC 2023
|
||
|
NCI_THESAURUS |
C66883
Created by
admin on Fri Dec 15 16:28:50 UTC 2023 , Edited by admin on Fri Dec 15 16:28:50 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
HALOPERIDOL
Created by
admin on Fri Dec 15 16:28:50 UTC 2023 , Edited by admin on Fri Dec 15 16:28:50 UTC 2023
|
PRIMARY | Description: A white to faintly yellowish, amorphous or microcrystalline powder; odourless. Solubility: Practically insoluble in water; soluble in 50 parts of ethanol (~750 g/l) TS and in 200 parts of ether R. Category: Neuroleptic. Storage: Haloperidol should be kept in a well-closed container, protected from light. Definition: Haloperidol contains not less than 98.0% and not more than 101.0% of C21H23ClFNO2, calculated with reference to the dried substance. | ||
|
86
Created by
admin on Fri Dec 15 16:28:50 UTC 2023 , Edited by admin on Fri Dec 15 16:28:50 UTC 2023
|
PRIMARY | |||
|
1303002
Created by
admin on Fri Dec 15 16:28:50 UTC 2023 , Edited by admin on Fri Dec 15 16:28:50 UTC 2023
|
PRIMARY | |||
|
5613
Created by
admin on Fri Dec 15 16:28:50 UTC 2023 , Edited by admin on Fri Dec 15 16:28:50 UTC 2023
|
PRIMARY | |||
|
DB00502
Created by
admin on Fri Dec 15 16:28:50 UTC 2023 , Edited by admin on Fri Dec 15 16:28:50 UTC 2023
|
PRIMARY | |||
|
J6292F8L3D
Created by
admin on Fri Dec 15 16:28:50 UTC 2023 , Edited by admin on Fri Dec 15 16:28:50 UTC 2023
|
PRIMARY | |||
|
3093
Created by
admin on Fri Dec 15 16:28:50 UTC 2023 , Edited by admin on Fri Dec 15 16:28:50 UTC 2023
|
PRIMARY | |||
|
Haloperidol
Created by
admin on Fri Dec 15 16:28:50 UTC 2023 , Edited by admin on Fri Dec 15 16:28:50 UTC 2023
|
PRIMARY | |||
|
HALOPERIDOL
Created by
admin on Fri Dec 15 16:28:50 UTC 2023 , Edited by admin on Fri Dec 15 16:28:50 UTC 2023
|
PRIMARY | |||
|
J6292F8L3D
Created by
admin on Fri Dec 15 16:28:50 UTC 2023 , Edited by admin on Fri Dec 15 16:28:50 UTC 2023
|
PRIMARY | |||
|
5093
Created by
admin on Fri Dec 15 16:28:50 UTC 2023 , Edited by admin on Fri Dec 15 16:28:50 UTC 2023
|
PRIMARY | RxNorm | ||
|
52-86-8
Created by
admin on Fri Dec 15 16:28:50 UTC 2023 , Edited by admin on Fri Dec 15 16:28:50 UTC 2023
|
PRIMARY | |||
|
3559
Created by
admin on Fri Dec 15 16:28:50 UTC 2023 , Edited by admin on Fri Dec 15 16:28:50 UTC 2023
|
PRIMARY | |||
|
CHEMBL54
Created by
admin on Fri Dec 15 16:28:50 UTC 2023 , Edited by admin on Fri Dec 15 16:28:50 UTC 2023
|
PRIMARY | |||
|
D006220
Created by
admin on Fri Dec 15 16:28:50 UTC 2023 , Edited by admin on Fri Dec 15 16:28:50 UTC 2023
|
PRIMARY | |||
|
200-155-6
Created by
admin on Fri Dec 15 16:28:50 UTC 2023 , Edited by admin on Fri Dec 15 16:28:50 UTC 2023
|
PRIMARY | |||
|
m5904
Created by
admin on Fri Dec 15 16:28:50 UTC 2023 , Edited by admin on Fri Dec 15 16:28:50 UTC 2023
|
PRIMARY | Merck Index | ||
|
615296
Created by
admin on Fri Dec 15 16:28:50 UTC 2023 , Edited by admin on Fri Dec 15 16:28:50 UTC 2023
|
PRIMARY | |||
|
C537
Created by
admin on Fri Dec 15 16:28:50 UTC 2023 , Edited by admin on Fri Dec 15 16:28:50 UTC 2023
|
PRIMARY | |||
|
DTXSID4034150
Created by
admin on Fri Dec 15 16:28:50 UTC 2023 , Edited by admin on Fri Dec 15 16:28:50 UTC 2023
|
PRIMARY | |||
|
100000092645
Created by
admin on Fri Dec 15 16:28:50 UTC 2023 , Edited by admin on Fri Dec 15 16:28:50 UTC 2023
|
PRIMARY | |||
|
SUB08005MIG
Created by
admin on Fri Dec 15 16:28:50 UTC 2023 , Edited by admin on Fri Dec 15 16:28:50 UTC 2023
|
PRIMARY | |||
|
918
Created by
admin on Fri Dec 15 16:28:50 UTC 2023 , Edited by admin on Fri Dec 15 16:28:50 UTC 2023
|
PRIMARY | |||
|
170973
Created by
admin on Fri Dec 15 16:28:50 UTC 2023 , Edited by admin on Fri Dec 15 16:28:50 UTC 2023
|
PRIMARY | |||
|
1353
Created by
admin on Fri Dec 15 16:28:50 UTC 2023 , Edited by admin on Fri Dec 15 16:28:50 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET->INVERSE AGONIST |
Ki
|
||
|
SALT/SOLVATE -> PARENT |
|
||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (TITRATION)
USP
|
||
|
TARGET -> AGONIST |
BINDING
IC50
|
||
|
METABOLIC ENZYME -> SUBSTRATE | |||
|
BINDER->LIGAND |
BINDING
|
||
|
BASIS OF STRENGTH->SUBSTANCE |
ASSAY (TITRATION)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE TOXIC -> PARENT |
|
||
|
METABOLITE -> PARENT |
|
||
|
METABOLITE -> PARENT | |||
|
METABOLITE -> PARENT |
|
||
|
PARENT -> METABOLITE |
|
||
|
METABOLITE INACTIVE -> PARENT |
|
||
|
PRODRUG -> METABOLITE ACTIVE |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
||
|
PARENT -> IMPURITY |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
USP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|